咪达唑仑口服溶液对于TEP小儿术前焦虑和术后烦躁的影响

注册号:

Registration number:

ChiCTR2600124292 

最近更新日期:

Date of Last Refreshed on:

2026-05-09 17:07:13 

注册时间:

Date of Registration:

2026-05-09 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

咪达唑仑口服溶液对于TEP小儿术前焦虑和术后烦躁的影响

Public title:

The Effects of Oral Midazolam Solution on Preoperative Anxiety and Postoperative Agitation in Pediatric Patients Undergoing Total Extraperitoneal Procedure (TEP)

注册题目简写:

English Acronym:

研究课题的正式科学名称:

咪达唑仑口服溶液对于TEP小儿术前焦虑和术后烦躁的影响

Scientific title:

The Effects of Oral Midazolam Solution on Preoperative Anxiety and Postoperative Agitation in Pediatric Patients Undergoing Total Extraperitoneal Procedure (TEP)

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

钟正 

研究负责人:

钟正 

Applicant:

Zhong Zheng 

Study leader:

Zhong Zheng 

申请注册联系人电话:

Applicant telephone:

+86 28 3823 5337

研究负责人电话:

Study leader's
telephone:

+86 28 3823 5337

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

841528584@qq.com

研究负责人电子邮件:

Study leader's E-mail:

841528584@qq.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

四川省眉山市东坡区东坡大道南4段288号

研究负责人通讯地址:

四川省眉山市东坡区东坡大道南4段288号

Applicant address:

No. 288, Section 4, Dongpo Avenue South, Dongpo District, Meishan City, Sichuan Province

Study leader's address:

No. 288, Section 4, Dongpo Avenue South, Dongpo District, Meishan City, Sichuan Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

眉山市人民医院

Applicant's institution:

Meishan City People's Hospital

研究负责人所在单位:

眉山市人民医院

Affiliation of the Leader:

Meishan City Peoples Hospital

是否获伦理委员会批准:

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

MY-IBR20250136

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

眉山市人民医院伦理委员会

Name of the ethic committee:

Ethics Committee of Meishan City People's Hospital

伦理委员会批准日期:

Date of approved by ethic committee:

2025-12-12 00:00:00

伦理委员会联系人:

王秋婷

Contact Name of the ethic committee:

Wang Qiuting

伦理委员会联系地址:

四川省眉山市东坡区东坡大道南4段288号

Contact Address of the ethic committee:

No. 288, Section 4, Dongpo Avenue South, Dongpo District, Meishan City, Sichuan Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 28 38235337

伦理委员会联系人邮箱:

Contact email of the ethic committee:

630191908@qq.com

研究实施负责(组长)单位:

眉山市人民医院

Primary sponsor:

Meishan City Peoples Hospital

研究实施负责(组长)单位地址:

四川省眉山市东坡区东坡大道南4段288号

Primary sponsor's address:

No. 288, Section 4, Dongpo Avenue South, Dongpo District, Meishan City, Sichuan Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

四川省

市(区县):

Country:

China

Province:

Sichuan

City:

单位(医院):

眉山市人民医院

具体地址:

四川省眉山市东坡区东坡大道南4段288号

Institution
hospital:

Meishan City Peoples Hospital

Address:

No. 288, Section 4, Dongpo Avenue South, Dongpo District, Meishan City, Sichuan Province

经费或物资来源:

自筹

Source(s) of funding:

self-financed

研究疾病:

小儿腹股沟疝  

Target disease:

pediatric inguinal hernia

研究疾病代码:

Target disease code:

研究类型:

干预性研究

Study type:

Interventional study

研究所处阶段:

上市后药物 

Study phase:

4

研究设计:

随机平行对照 

Study design:

Parallel 

研究目的:

探讨术前半小时口服咪达唑仑口服溶液对于行腹腔镜腹股沟疝修补术(TEP)小儿术前焦虑和术后烦躁的影响。  

Objectives of Study:

To investigate the effect of oral midazolam oral solution administered half an hour before surgery on preoperative anxiety and postoperative agitation in children undergoing laparoscopic totally extraperitoneal inguinal hernia repair (TEP)

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

Inclusion criteria

排除标准:

1.对咪达唑仑或苯二氮䓬类药物过敏,或对研究中使用的苹果汁等辅料过敏;
2.存在中枢神经系统疾病、精神发育迟滞、自闭症等影响情绪评估的疾病;
3.有呼吸功能不全、肝肾功能异常、心血管疾病等严重基础疾病;
4.术前 48 小时内使用过镇静催眠药、抗焦虑药或其他可能影响情绪状态的药物;
5.手术当天出现发热(体温≥38.5℃)、咳嗽、呕吐等急性感染症状;
6.患儿家属无法配合完成数据采集或随访,或存在其他影响研究实施的情况;

Exclusion criteria:

1.Hypersensitivity to midazolam, benzodiazepines, or excipients such as apple juice used in the study;
2.Presence of central nervous system diseases, mental retardation, autism, or other conditions that affect emotional assessment;
3.Presence of severe underlying diseases including respiratory insufficiency, abnormal hepatic and renal function, cardiovascular diseases, etc;
4.Administration of sedative-hypnotics, anxiolytics, or other medications that may affect emotional status within 48 hours preoperatively;
5.On the day of surgery, acute infectious symptoms such as fever (body temperature ≥ 38.5°C), cough, vomiting, etc;
6.The children's guardians cannot cooperate with data collection or follow-up, or there are other circumstances that affect the implementation of the study;

研究实施时间:

Study execute time:

From 2026-03-01 00:00:00 To 2028-03-01 00:00:00  

征募观察对象时间:

Recruiting time:

From 2026-06-01 00:00:00 To 2027-09-30 00:00:00

干预措施:

Interventions:

组别:

干预组

样本量:

30

Group:

Intervention group

Sample size:

干预措施:

术前 30 分钟口服咪达唑仑(0.5mg/kg,最大用量 15mg,混 5mL苹果汁)+常规护理

干预措施代码:

Intervention:

Oral midazolam 30 minutes before surgery (0.5 mg/kg, maximum dose 15 mg, mixed in 5 mL apple juice) Routine care

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

术前 30 分钟口服 5ml 苹果汁+常规护理

干预措施代码:

Intervention:

Orally take 5ml of apple juice 30 minutes before surgery, routine care

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

四川省 

市(区县):

 

Country:

China

Province:

Sichuan

City:

单位(医院):

眉山市人民医院 

单位级别:

三级甲等 

Institution
hospital:

Meishan City Peoples Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

儿童麻醉苏醒期躁动评分量表(PAED)评分

指标类型:

次要指标

Outcome:

Pediatric Anesthesia Emergence Delirium (PAED) Scale Score

Type:

Secondary indicator

测量时间点:

苏醒时;术后1小时

测量方法:

Measure time point of outcome:

Upon awakening; 1 hour after surgery

Measure method:

指标中文名:

改良耶鲁术前焦虑量表(m-YPAS)评分

指标类型:

主要指标

Outcome:

Modified Yale Preoperative Anxiety Scale (m-YPAS) Score

Type:

Primary indicator

测量时间点:

入室前30分钟;入室前15分钟;入室前

测量方法:

Measure time point of outcome:

30 minutes before entering the operating room; 15 minutes before entering the operating room; immedi

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

None

Tissue:

人体标本去向

其它  

说明

Fate of sample:

0thers  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age 2 years
最大 Max age 7 years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

由研究者按随机数字表分为两组

Randomization Procedure (please state who generates the random number sequence and by what method):

The patients will be randomly divided into two groups using a random number table by the investigators

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

对评估者设盲

Blinding:

Blinding of the evaluator

是否共享原始数据:

IPD sharing

否No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

None

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

CRF

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

CRF

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2026-05-09 17:07:04